ML-guided CRISPRi combinations improve isoprenol production
An ensemble of machine-learning regressors recommended combinations of up to four CRISPRi guide RNAs during six design–build–test–learn cycles in engineered Pseudomonas putida. The paper reports an approximately fivefold isoprenol-titer improvement over its control for highlighted strains. It reports 347 unique arrays for the highlighted optimization and 472 unique strains overall; these are different denominators. A 2024 DOE meeting abstract describes an earlier campaign but does not quantify the later result; the journal article date is used without claiming first public disclosure. The finding is specific to this strain and laboratory workflow, not industrial fuel production.
Technology: Automated Recommendation Tool ensemble of machine-learning regressors
Publication: Peer-reviewed paper · Test context: direct test. Catalog categories, not an evidence grade.
Result, AI contribution and limits
Evidence context (descriptions follow the cited sources; test type is a catalog classification):
- Publication status: Peer-reviewed paper
- Test type: direct test
- Tested: The article reports six optimization cycles and about fivefold higher isoprenol titer versus the stated control, with distinct counts of 347 unique arrays and 472 unique strains overall.
- Still unknown: The result is study-specific; industrial scale-up and independent replication are not established. The earlier DOE abstract establishes a related campaign, not the later quantitative result.
- AI role: The Automated Recommendation Tool, an ensemble of ML regressors, recommended guide-RNA combinations after initial genes and training data were supplied by researchers.
Evidence sources: https://www.nature.com/articles/s41467-025-66304-8_reference.pdf
Source checked · editorial details
The source page was checked against this entry. Independent confirmation is not assessed by this label.
Source type: paper. Paper: not linked in this catalog; this does not mean no paper exists.
Review date: 16 Nov 2026. Review scope: Primary publisher article/PDF and institutional preprint metadata reviewed for identity, bounded outcomes, AI role, affiliations and chronology..
Editorial assessment: Impact 3/5 · Validation 3/5 · Novelty 3/5. Impact and novelty are editorial judgments; validation follows the annotated test type where one exists. Not an evidence grade. Scoring criteria.
Follow-up and relationships
No follow-up recorded; this is not a claim that no follow-up exists.
Follow-up review scope and date are not recorded.
No source-supported relationships recorded.